Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 24231 | 319 | 27.7 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
| 346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
| 2227 | 2 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN | 4791 |
| 24231 | 1 | CARDIOTOXICITY//INTERNAL MED PERIOPERAT ASSESSMENT//5 FLUOROURACIL | 319 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CARDIOTOXICITY | authKW | 411087 | 29% | 5% | 92 |
| 2 | INTERNAL MED PERIOPERAT ASSESSMENT | address | 191443 | 1% | 100% | 2 |
| 3 | 5 FLUOROURACIL | authKW | 147427 | 26% | 2% | 82 |
| 4 | 5 FLUOROURACIL ADVERSE REACTION | authKW | 95722 | 0% | 100% | 1 |
| 5 | 5 FLUOROURACIL SUSTAINED RELEASE PARTICLES | authKW | 95722 | 0% | 100% | 1 |
| 6 | 5 FU EFFORT ISCHEMIA | authKW | 95722 | 0% | 100% | 1 |
| 7 | 5 FU THERAPEUTIC MONITORING | authKW | 95722 | 0% | 100% | 1 |
| 8 | 6 CHLORO ANALOG OF PYRVINIUM IODIDE | authKW | 95722 | 0% | 100% | 1 |
| 9 | ADJUVANT INTRAPERITONEAL THERAPY | authKW | 95722 | 0% | 100% | 1 |
| 10 | ADJUVANT PORTAL LIVER IN FUSION | authKW | 95722 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 2481 | 46% | 0% | 146 |
| 2 | Cardiac & Cardiovascular System | 428 | 15% | 0% | 49 |
| 3 | Medicine, General & Internal | 208 | 13% | 0% | 42 |
| 4 | Pharmacology & Pharmacy | 197 | 17% | 0% | 53 |
| 5 | Peripheral Vascular Diseases | 49 | 4% | 0% | 14 |
| 6 | Toxicology | 19 | 3% | 0% | 10 |
| 7 | Microscopy | 19 | 1% | 0% | 3 |
| 8 | Medicine, Research & Experimental | 8 | 3% | 0% | 10 |
| 9 | Critical Care Medicine | 7 | 1% | 0% | 4 |
| 10 | Emergency Medicine | 4 | 1% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INTERNAL MED PERIOPERAT ASSESSMENT | 191443 | 1% | 100% | 2 |
| 2 | ADULT MED ONCOL ONCOL HEMATOL | 95722 | 0% | 100% | 1 |
| 3 | AMBULATORY ECHOCARDIOG | 95722 | 0% | 100% | 1 |
| 4 | C GOLGI GEN PATHOL | 95722 | 0% | 100% | 1 |
| 5 | CARDIOL CLIN 6 | 95722 | 0% | 100% | 1 |
| 6 | CARDIOL UNIT CANC | 95722 | 0% | 100% | 1 |
| 7 | CARDIOVASC ALTERNAT MED 3375 | 95722 | 0% | 100% | 1 |
| 8 | CLIN 81 | 95722 | 0% | 100% | 1 |
| 9 | CLIN ONCOL CHEMOTHER Y 1 | 95722 | 0% | 100% | 1 |
| 10 | CRVA DRUG DISCOVERY | 95722 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | TUMORI | 3451 | 4% | 0% | 13 |
| 2 | CLINICAL COLORECTAL CANCER | 3244 | 1% | 1% | 4 |
| 3 | JOURNAL OF CARDIOVASCULAR MEDICINE | 2044 | 2% | 0% | 6 |
| 4 | JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 1855 | 1% | 1% | 2 |
| 5 | HIPPOKRATIA | 1418 | 1% | 0% | 3 |
| 6 | ONCOLOGY | 1183 | 2% | 0% | 7 |
| 7 | ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE | 1046 | 1% | 0% | 4 |
| 8 | CHEMOTHERAPY | 936 | 2% | 0% | 5 |
| 9 | BULLETIN DU CANCER | 810 | 2% | 0% | 6 |
| 10 | CANCER RESEARCH THERAPY & CONTROL | 734 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | SAIF, MW , SHAH, MM , SHAH, AR , (2009) FLUOROPYRIMIDINE-ASSOCIATED CARDIOTOXICITY: REVISITED.EXPERT OPINION ON DRUG SAFETY. VOL. 8. ISSUE 2. P. 191-202 | 55 | 76% | 54 |
| 2 | SORRENTINO, MF , KIM, J , FODERARO, AE , TRUESDELL, AG , (2012) 5-FLUOROURACIL INDUCED CARDIOTOXICITY: REVIEW OF THE LITERATURE.CARDIOLOGY JOURNAL. VOL. 19. ISSUE 5. P. 453-458 | 39 | 93% | 40 |
| 3 | LAYOUN, ME , WICKRAMASINGHE, CD , PERALTA, MV , YANG, EH , (2016) FLUOROPYRIMIDINE-INDUCED CARDIOTOXICITY: MANIFESTATIONS, MECHANISMS, AND MANAGEMENT.CURRENT ONCOLOGY REPORTS. VOL. 18. ISSUE 6. P. - | 43 | 80% | 0 |
| 4 | BECKER, K , ERCKENBRECHT, JF , HAUSSINGER, D , FRIELING, T , (1999) CARDIOTOXICITY OF THE ANTIPROLIFERATIVE COMPOUND FLUOROURACIL.DRUGS. VOL. 57. ISSUE 4. P. 475-484 | 57 | 84% | 83 |
| 5 | POLK, A , VAAGE-NILSEN, M , VISTISEN, K , NIELSEN, DL , (2013) CARDIOTOXICITY IN CANCER PATIENTS TREATED WITH 5-FLUOROURACIL OR CAPECITABINE: A SYSTEMATIC REVIEW OF INCIDENCE, MANIFESTATIONS AND PREDISPOSING FACTORS.CANCER TREATMENT REVIEWS. VOL. 39. ISSUE 8. P. 974-984 | 34 | 71% | 33 |
| 6 | POLK, A , VISTISEN, K , VAAGE-NILSEN, M , NIELSEN, DL , (2014) A SYSTEMATIC REVIEW OF THE PATHOPHYSIOLOGY OF 5-FLUOROURACIL-INDUCED CARDIOTOXICITY.BMC PHARMACOLOGY & TOXICOLOGY. VOL. 15. ISSUE . P. - | 39 | 54% | 22 |
| 7 | LESTUZZI, C , VACCHER, E , TALAMINI, R , LLESHI, A , MENEGUZZO, N , VIEL, E , SCALONE, S , TARTUFERI, L , BUONADONNA, A , EJIOFOR, L , ET AL (2014) EFFORT MYOCARDIAL ISCHEMIA DURING CHEMOTHERAPY WITH 5-FLUOROURACIL: AN UNDERESTIMATED RISK.ANNALS OF ONCOLOGY. VOL. 25. ISSUE 5. P. 1059 -1064 | 22 | 96% | 8 |
| 8 | POLK, A , SHAHMARVAND, N , VISTISEN, K , VAAGE-NILSEN, M , LARSEN, FO , SCHOU, M , NIELSEN, DL , (2016) INCIDENCE AND RISK FACTORS FOR CAPECITABINE-INDUCED SYMPTOMATIC CARDIOTOXICITY: A RETROSPECTIVE STUDY OF 452 CONSECUTIVE PATIENTS WITH METASTATIC BREAST CANCER.BMJ OPEN. VOL. 6. ISSUE 10. P. - | 23 | 77% | 1 |
| 9 | FRANCIS, N , (2014) THE NEED FOR ROUTINE MONITORING OF CARDIAC FUNCTION IN PATIENTS RECEIVING 5-FLUOROURACIL INFUSION.CLINICAL JOURNAL OF ONCOLOGY NURSING. VOL. 18. ISSUE 3. P. 360-362 | 18 | 100% | 0 |
| 10 | BATHINA, JD , YUSUF, SW , (2010) 5-FLUOROURACIL-INDUCED CORONARY VASOSPASM.JOURNAL OF CARDIOVASCULAR MEDICINE. VOL. 11. ISSUE 4. P. 281-284 | 20 | 91% | 6 |
Classes with closest relation at Level 1 |